Prognostic significance of in vivo sensitivity to chemotherapy for patients with limited, unresectable, non-small cell lung cancer (NSCLC)

T. P. Miller, S. L. Davis, M. R. Manning

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)C-596
JournalProceedings of the American Society of Clinical Oncology
VolumeVol. 1
StatePublished - 1982

ASJC Scopus subject areas

  • General Medicine

Cite this